The triple-negative breast cancer (TNBC) subtype [i.e. lacking expression (or overexpression) of ER and HER2, as well as progesterone receptor (PR)] is specifically associated with a poor prognosis and a highly metastatic phenotype. The gene discussed is PGR; the disease is triple-negative breast carcinoma.